Abstract
Receptors for products of non-enzymatic glycosylation have been identified previously on activated human monocytes. In this study we have found that medium conditioned by activated human monocytes following stimulation with AGE-BSA elicited an almost 3-fold greater chemotactic response from other activated monocytes than conditioned medium obtained following stimulation with control BSA (44 ± 13 and 16 ± 4.6, respectively; n = 9, P < 0.05). The response elicited from AGE-BSA alone was not statistically significant. It appears that stimulation of the cells via the AGE-receptor results in the secretion of increased levels of a chemotactic substance(s) for monocytes/macrophages. This mechanism may help to explain the pathogenesis of atherosclerosis in diabetes, as monocyte accumulation within the vessel wall is an important step in fatty streak development.
Original language | English (US) |
---|---|
Pages (from-to) | 7-11 |
Number of pages | 5 |
Journal | Diabetes Research and Clinical Practice |
Volume | 16 |
Issue number | 1 |
DOIs | |
State | Published - Apr 1992 |
Keywords
- AGE-receptor
- Chemotaxis
- Diabetes
- Monocyte
- Non-enzymatic glycosylation
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology